47 related articles for article (PubMed ID: 12070006)
1. Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemia.
Sandlund JT; Harrison PL; Rivera G; Behm FG; Head D; Boyett J; Rubnitz JE; Gajjar A; Raimondi S; Ribeiro R; Hudson M; Relling M; Evans W; Pui CH
Blood; 2002 Jul; 100(1):43-7. PubMed ID: 12070006
[TBL] [Abstract][Full Text] [Related]
2. PROGNOSIS OF THE COURSE OF CHORNOBYL-ORIGINATED ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN IN UKRAINE DEPENDING ON THE REASON OF STANDARD CHEMOTHERAPY INTERRUPTION.
Bebeshko VG; Bruslova KM; Tsvetkova NM; Lyashenko LO; Pushkariova TI; Gonchar LO; Tryhlib IV; Yatsemirskyi SM; Samson YM; Boyarskyi VG; Grischenko KV; Polyanska VM; Dmytrenko IV
Probl Radiac Med Radiobiol; 2019 Dec; 24():335-349. PubMed ID: 31841478
[TBL] [Abstract][Full Text] [Related]
3. [Long-term outcome of childhood T-cell acute lymphoblastic leukemia treated with modified national protocol of childhood leukemia in China-acute lymphoblastic leukemia 2008].
Liao C; Shen DY; Xu XJ; Xu WQ; Zhang JY; Song H; Yang SL; Zhao FY; Shen HP; Tang YM
Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):758-763. PubMed ID: 32872717
[No Abstract] [Full Text] [Related]
4. Analysis of clinical profile and role of various prognostic factors in early bone marrow response in children with acute lymphoblastic leukemia treated by Modified Multicenter Protocol (MCP) 841 protocol: Experience from a tertiary care center in North India.
Garg M; Abrol P; Gupta N; Bharti S; Nadda A
Indian J Cancer; 2023 Oct; 60(4):521-527. PubMed ID: 38258870
[TBL] [Abstract][Full Text] [Related]
5. Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemia.
Advani AS; Jin T; Ramsingh G; Tiu R; Saber W; Theil K; Sobecks R; Sekeres M; Copelan E; Sungren S; Tripp B; Kalaycio M
Leuk Lymphoma; 2008 Aug; 49(8):1560-6. PubMed ID: 18766970
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of CD45 antigen expression in pediatric acute lymphoblastic leukemia.
Balasubramanian P; Singh J; Verma D; Kumar R; Bakhshi S; Tanwar P; Singh AR; Chopra A
Blood Cells Mol Dis; 2021 Jul; 89():102562. PubMed ID: 33756412
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of SET and MYND domain-containing protein 2 (
Zhang P; Ruan J; Weng W; Tang Y
Leuk Lymphoma; 2020 Feb; 61(2):437-444. PubMed ID: 31612757
[TBL] [Abstract][Full Text] [Related]
8. Can CD34
Stolpa W; Mizia-Malarz A; Zapała M; Zwiernik B
Front Pediatr; 2023; 11():1213009. PubMed ID: 37675394
[TBL] [Abstract][Full Text] [Related]
9. Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence.
Heydt Q; Xintaropoulou C; Clear A; Austin M; Pislariu I; Miraki-Moud F; Cutillas P; Korfi K; Calaminici M; Cawthorn W; Suchacki K; Nagano A; Gribben JG; Smith M; Cavenagh JD; Oakervee H; Castleton A; Taussig D; Peck B; Wilczynska A; McNaughton L; Bonnet D; Mardakheh F; Patel B
Nat Commun; 2021 Sep; 12(1):5507. PubMed ID: 34535653
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy.
Lontos K; Tsagianni A; Agha M; Raptis A; Hou JZ; Farah R; Redner RL; Im A; Dorritie KA; Sehgal A; Rossetti J; Aggarwal N; Saul M; Boyiadzis M; Bailey NG
Leuk Lymphoma; 2023 Mar; 64(3):750-752. PubMed ID: 36722791
[No Abstract] [Full Text] [Related]
11. [The prognostic significance of proportion of blasts in bone marrow on day 14 during induction chemotherapy in patients with adult Ph-negative acute lymphoblastic leukemia].
Jia JS; Yang SM; Wang J; Jiang H; Zhao T; Bao L; Shi HX; Lu J; Zhu HH; Lai YY; Jiang B; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2016 Jun; 37(6):497-502. PubMed ID: 27431075
[TBL] [Abstract][Full Text] [Related]
12. Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia.
Dai H; Zhang W; Li X; Han Q; Guo Y; Zhang Y; Wang Y; Wang C; Shi F; Zhang Y; Chen M; Feng K; Wang Q; Zhu H; Fu X; Li S; Han W
Oncoimmunology; 2015 Nov; 4(11):e1027469. PubMed ID: 26451310
[TBL] [Abstract][Full Text] [Related]
13. Results of treatment of advanced-stage lymphoblastic lymphoma at St Jude Children's Research Hospital from 1962 to 2002.
Sandlund JT; Pui CH; Zhou Y; Onciu M; Campana D; Hudson MM; Inaba H; Metzger ML; Bhojwani D; Ribeiro RC
Ann Oncol; 2013 Sep; 24(9):2425-9. PubMed ID: 23788752
[TBL] [Abstract][Full Text] [Related]
14. Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia.
Lauten M; Möricke A; Beier R; Zimmermann M; Stanulla M; Meissner B; Odenwald E; Attarbaschi A; Niemeyer C; Niggli F; Riehm H; Schrappe M
Haematologica; 2012 Jul; 97(7):1048-56. PubMed ID: 22271901
[TBL] [Abstract][Full Text] [Related]
15. Progress of minimal residual disease studies in childhood acute leukemia.
Campana D
Curr Hematol Malig Rep; 2010 Jul; 5(3):169-76. PubMed ID: 20467922
[TBL] [Abstract][Full Text] [Related]
16. Role of minimal residual disease evaluation in leukemia therapy.
Campana D
Curr Hematol Malig Rep; 2008 Jul; 3(3):155-60. PubMed ID: 20425460
[TBL] [Abstract][Full Text] [Related]
17. Role of minimal residual disease monitoring in adult and pediatric acute lymphoblastic leukemia.
Campana D
Hematol Oncol Clin North Am; 2009 Oct; 23(5):1083-98, vii. PubMed ID: 19825454
[TBL] [Abstract][Full Text] [Related]
18. High-risk childhood acute lymphoblastic leukemia.
Bhojwani D; Howard SC; Pui CH
Clin Lymphoma Myeloma; 2009; 9 Suppl 3(Suppl 3):S222-30. PubMed ID: 19778845
[TBL] [Abstract][Full Text] [Related]
19. Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study.
Sandlund JT; Pui CH; Zhou Y; Behm FG; Onciu M; Razzouk BI; Hijiya N; Campana D; Hudson MM; Ribeiro RC
Leukemia; 2009 Jun; 23(6):1127-30. PubMed ID: 19194463
[TBL] [Abstract][Full Text] [Related]
20. Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study.
Gandemer V; Auclerc MF; Perel Y; Vannier JP; Le Gall E; Demeocq F; Schmitt C; Piguet C; Stephan JL; Lejars O; Debre M; Jonveaux P; Cayuela JM; Chevret S; Leverger G; Baruchel A;
BMC Cancer; 2009 Jan; 9():14. PubMed ID: 19144139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
